311 related articles for article (PubMed ID: 30119255)
21. LncRNA FTX inhibition restrains osteosarcoma proliferation and migration via modulating miR-320a/TXNRD1.
Huang S; Zhu X; Ke Y; Xiao D; Liang C; Chen J; Chang Y
Cancer Biol Ther; 2020 Apr; 21(4):379-387. PubMed ID: 31920141
[TBL] [Abstract][Full Text] [Related]
22. Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2.
Zhang CL; Zhu KP; Ma XL
Cancer Lett; 2017 Jun; 396():66-75. PubMed ID: 28323030
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195.
Zhou Q; Chen F; Zhao J; Li B; Liang Y; Pan W; Zhang S; Wang X; Zheng D
Oncotarget; 2016 Dec; 7(50):82620-82633. PubMed ID: 27813492
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of Long Non-Coding RNA Small Nucleolar RNA Host Gene 12 Contributes to Cell Growth and Invasion in Cervical Cancer by Acting as a Sponge for MiR-424-5p.
Dong J; Wang Q; Li L; Xiao-Jin Z
Cell Physiol Biochem; 2018; 45(5):2086-2094. PubMed ID: 29533945
[TBL] [Abstract][Full Text] [Related]
25. LncRNA highly upregulated in liver cancer regulates imatinib resistance in chronic myeloid leukemia via the miR-150-5p/MCL1 axis.
Han Y; Ma Z
Anticancer Drugs; 2021 Apr; 32(4):427-436. PubMed ID: 33587348
[TBL] [Abstract][Full Text] [Related]
26. Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance.
Liu T; Li Z; Zhang Q; De Amorim Bernstein K; Lozano-Calderon S; Choy E; Hornicek FJ; Duan Z
Oncotarget; 2016 Dec; 7(50):83502-83513. PubMed ID: 27835872
[TBL] [Abstract][Full Text] [Related]
27. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
Li G; Liu K; Du X
Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.
Zhu KP; Zhang CL; Shen GQ; Zhu ZS
Int J Clin Exp Pathol; 2015; 8(8):8754-73. PubMed ID: 26464619
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326 and promotes tumorigenesis in osteosarcoma.
Wang J; Cao L; Wu J; Wang Q
Int J Oncol; 2018 Jan; 52(1):77-88. PubMed ID: 29115574
[TBL] [Abstract][Full Text] [Related]
30. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1.
Long X; Lin XJ
J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173
[TBL] [Abstract][Full Text] [Related]
31. A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma.
Zhang CL; Zhu KP; Shen GQ; Zhu ZS
Tumour Biol; 2016 Feb; 37(2):2737-48. PubMed ID: 26408180
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA AFAP1‑AS1 enhances cell proliferation and invasion in osteosarcoma through regulating miR‑4695‑5p/TCF4‑β‑catenin signaling.
Li R; Liu S; Li Y; Tang Q; Xie Y; Zhai R
Mol Med Rep; 2018 Aug; 18(2):1616-1622. PubMed ID: 29901121
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223.
Dai J; Xu L; Hu X; Han G; Jiang H; Sun H; Zhu G; Tang X
Biomed Pharmacother; 2018 Oct; 106():1441-1447. PubMed ID: 30119217
[TBL] [Abstract][Full Text] [Related]
34. SNHG16 promotes osteosarcoma progression and enhances cisplatin resistance by sponging miR-16 to upregulate ATG4B expression.
Liu Y; Gu S; Li H; Wang J; Wei C; Liu Q
Biochem Biophys Res Commun; 2019 Oct; 518(1):127-133. PubMed ID: 31427084
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA LINC00426 contributes to doxorubicin resistance by sponging miR-4319 in osteosarcoma.
Wang L; Luo Y; Zheng Y; Zheng L; Lin W; Chen Z; Wu S; Chen J; Xie Y
Biol Direct; 2020 Jul; 15(1):11. PubMed ID: 32620145
[TBL] [Abstract][Full Text] [Related]
36. Doxorubicin Inhibits Proliferation of Osteosarcoma Cells Through Upregulation of the Notch Signaling Pathway.
Ji P; Yu L; Guo WC; Mei HJ; Wang XJ; Chen H; Fang S; Yang J
Oncol Res; 2014; 22(4):185-191. PubMed ID: 26351207
[TBL] [Abstract][Full Text] [Related]
37. Fibronectin-1 modulated by the long noncoding RNA OIP5-AS1/miR-200b-3p axis contributes to doxorubicin resistance of osteosarcoma cells.
Kun-Peng Z; Chun-Lin Z; Xiao-Long M; Lei Z
J Cell Physiol; 2019 May; 234(5):6927-6939. PubMed ID: 30204936
[TBL] [Abstract][Full Text] [Related]
38. Circular RNA LARP4 correlates with decreased Enneking stage, better histological response, and prolonged survival profiles, and it elevates chemosensitivity to cisplatin and doxorubicin via sponging microRNA-424 in osteosarcoma.
Hu Y; Gu J; Shen H; Shao T; Li S; Wang W; Yu Z
J Clin Lab Anal; 2020 Feb; 34(2):e23045. PubMed ID: 31642110
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes tumorigenesis and metastasis by targeting miR-199a/b-5p in hepatocellular carcinoma.
Lan T; Ma W; Hong Z; Wu L; Chen X; Yuan Y
J Exp Clin Cancer Res; 2017 Jan; 36(1):11. PubMed ID: 28073380
[TBL] [Abstract][Full Text] [Related]
40. Long Noncoding RNA miR210HG Sponges miR-503 to Facilitate Osteosarcoma Cell Invasion and Metastasis.
Li J; Wu QM; Wang XQ; Zhang CQ
DNA Cell Biol; 2017 Dec; 36(12):1117-1125. PubMed ID: 28972855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
